Safety and efficacy of celecoxib, a specific COX-2 inhibitor, in patients with rheumatoid arthritis.

被引:0
|
作者
Geis, GS [1 ]
Hubbard, R [1 ]
Callison, D [1 ]
Yu, S [1 ]
Zhao, W [1 ]
机构
[1] GD Searle & Co, Skokie, IL 60077 USA
来源
ARTHRITIS AND RHEUMATISM | 1998年 / 41卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1990
引用
收藏
页码:S364 / S364
页数:1
相关论文
共 50 条
  • [1] Efficacy and safety of celecoxib, a specific COX-2 inhibitor, in patients with rheumatoid arthritis.
    Geis, GS
    Stead, H
    Morant, S
    Naudin, R
    Hubbard, R
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S316 - S316
  • [2] Efficacy and safety of celecoxib, a specific COX-2 inhibitor in patients with rheumatoid arthritis
    Geis, GS
    Hubbard, RC
    Callison, DA
    Yu, S
    Zhao, W
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (09) : S70 - S70
  • [3] Efficacy and safety of celecoxib, a specific COX-2 inhibitor, in osteoarthritis
    Geis, GS
    Hubbard, RC
    Woods, EM
    Yu, S
    Zhao, W
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (09) : S45 - S45
  • [4] Celecoxib: A COX-2 inhibitor for the treatment of osteoarthritis and rheumatoid arthritis
    Boyce, EG
    Breen, GA
    FORMULARY, 1999, 34 (05) : 405 - +
  • [5] Efficacy, tolerability, and safety of celecoxib, a specific COX-2 inhibitor, in osteoarthritis.
    Hubbard, R
    Geis, GS
    Woods, E
    Yu, S
    Zhao, W
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S196 - S196
  • [6] Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis
    Karim, A
    Tolbert, DS
    Hunt, TL
    Hubbard, RC
    Harper, KM
    Geis, GS
    JOURNAL OF RHEUMATOLOGY, 1999, 26 (12) : 2539 - 2543
  • [7] Valdecoxib, a new COX-2 specific inhibitor, is effective in treating the signs and symptoms of rheumatoid arthritis.
    Bensen, W
    Weaver, A
    Espinoza, L
    Riley, W
    Paperiello, B
    Recker, DP
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S369 - S369
  • [8] Satisfaction and preferences for NSAIDs and COX-2 specific inhibitors among patients with rheumatoid arthritis.
    Wolfe, F
    Michaud, K
    Zhao, SZ
    Burke, TA
    Pettitt, D
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S172 - S172
  • [9] Efficacy of celecoxib. A cox-2 specific inhibitor, in osteoarthritis of the hip.
    Geis, GS
    Hubbard, RC
    Woods, EM
    Lefkowith, JB
    Yu, S
    Zhao, W
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S144 - S144
  • [10] Celecoxib: A COX-2 inhibitor
    Andrews, SA
    Wallace, CK
    Davis, RL
    AMERICAN JOURNAL OF MANAGED CARE, 1999, 5 (04): : 511 - 518